European Survey of Prescriber Understanding of Risks Associated with Retigabine

Background We conducted a survey to assess physicians’ knowledge and understanding of key risks associated with retigabine. Objective The survey evaluated the effectiveness of the educational plan for retigabine, as specified in the GlaxoSmithKline (GSK) European Risk Management Plan. Methods This w...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	Drugs - real world outcomes Ročník 2; číslo 4; s. 345 - 353
Hlavní autori:	Ishihara, Lianna, Lewis, Anne, Kolli, Sathish, Brickel, Neil
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	Cham Springer International Publishing 01.12.2015 Springer Nature B.V
Predmet:	Confidence intervals Convulsions & seizures Drug dosages Internal Medicine Medicine Medicine & Public Health Multiple choice Performance evaluation Pharmacology/Toxicology Pharmacotherapy Physicians Questionnaires Short Communication United Kingdom > UK United States > US Norway Europe Denmark Slovakia Switzerland Germany Spain Educational Plan Central Nervous System Side Effect Retigabine Eligible Respondent Associate Confidence Interval
ISSN:	2199-1154, 2198-9788
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!